We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
What’s New in Treating the Anticoagulated Patient with ICH?
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Hiren C. Patel, PhD, FRCS
David Seiffge, MD
Thorsten Steiner, MD, PhD, MME
ESO Guidelines for the Management of ICH in the Anticoagulated Patient
Emerging Data on Reversal and Repletion for Anticoagulated Patients with ICH: The Neurocritical Care Perspective
Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
Audience Q&A with Panel
Evolving Our View of the Coagulation Cascade and Stroke Management
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management
Robert Shin, MD, FANA, FAAN
Enrique Alvarez, MD, PhD
Jiwon Oh, MD, PhD, FRCPC
Heads Up: It Might Be ATTRv Polyneuropathy – A Microlearning Course on Diagnosis and Treatment
John Berk, MD
Noel Dasgupta, MD, FACC
Sami Khella, MD
Marcia Waddington-Cruz, MD, PhD
ATTR Amyloidosis: Familial Vs Wild-Type
ATTRv-PN: A Family Affair?
The Multiple Faces of ATTRv-PN
Shh…Gene-Silencing Therapies for ATTRv-PN
Diagnosing ATTRv-PN: What's in Your Toolbox?
ATTRv-PN: A Complicated Disease With a Poor Prognosis
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education